NEW Dividiend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

Stryker Corporation SYK | NYSE

$338.02 $0.00 | 0.00%

Next Earnings: Aug 17, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
52-Week Range: $281.00 - $396.86

10 Year SYK Performance Metrics:

Total Return (with DRIP): 232.8% (12.78% CAGR)
Total Return (no DRIP): 221.6% (12.39% CAGR)
Share Price: 198.7% (11.57% CAGR)
Dividend Increase: 131.6% (8.76% CAGR)
Dividend Yield (FWD): 1.04% ($3.52)
SYK 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

SYK Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
SYK Dividend CAGR:1Y: 4.76%2Y: 4.88%5Y: 6.91%10Y: 8.76%
Share Price
SYK Price CAGR:1Y: -11.42%2Y: 0.02%5Y: 4.78%10Y: 11.57%

Unlock All Reports & Research Dividend Stocks.

[lev_ptables no_sale]

SYK Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - SYK
7-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - SYK
7-Day FREE Trial Get Full Access Now!

SYK Earnings, Revenue, Cash & Debt, Shares Outstaning:

SYK - Revenue
7-Day FREE Trial Get Full Access Now!
SYK Revenue CAGR:1Y: 9.42%2Y: 10.24%5Y: 8.94%10Y: 8.78%
SYK - Earnings Per Share (EPS)
7-Day FREE Trial Get Full Access Now!
SYK EPS CAGR:1Y: 44.10%2Y: 24.18%5Y: 16.32%10Y: 12.68%
SYK - Net Income
7-Day FREE Trial Get Full Access Now!
SYK Net Income CAGR:1Y: 44.34%2Y: 24.37%5Y: 16.60%10Y: 12.88%
SYK - EBITDA
7-Day FREE Trial Get Full Access Now!
SYK EBITDA CAGR:1Y: 6.32%2Y: 9.31%5Y: 6.81%10Y: 8.36%
SYK - Free Cash Flow
7-Day FREE Trial Get Full Access Now!
SYK Free Cash Flow CAGR:1Y: 14.12%2Y: 48.38%5Y: 6.53%10Y: 11.58%
SYK - Free Cash Flow / Share
7-Day FREE Trial Get Full Access Now!
SYK Free Cash Flow / Share CAGR:1Y: 13.73%2Y: 47.90%5Y: 6.16%10Y: 11.31%
SYK - Operating Income
7-Day FREE Trial Get Full Access Now!
SYK Operating Income CAGR:1Y: 21.90%2Y: 19.69%5Y: 17.78%10Y: 12.74%
SYK - Gross Profit
7-Day FREE Trial Get Full Access Now!
SYK Gross Profit CAGR:1Y: 19.95%2Y: 16.33%5Y: 10.17%10Y: 9.34%
SYK - Shares Outstanding
7-Day FREE Trial Get Full Access Now!
SYK Shares Outstanding CAGR:1Y: -0.10%2Y: 0.08%5Y: 0.19%10Y: 0.20%
SYK - Share Buybacks
7-Day FREE Trial Get Full Access Now!
SYK Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
SYK - Stock-Based Comp
7-Day FREE Trial Get Full Access Now!
SYK Stock-Based Comp CAGR:1Y: 10.20%2Y: 8.35%5Y: 6.72%10Y: 9.90%
SYK - Expenses
7-Day FREE Trial Get Full Access Now!
SYK Expenses CAGR:1Y: 10.38%2Y: 15.28%5Y: 13.77%10Y: 5.89%
SYK - Revenue vs Net Income
7-Day FREE Trial Get Full Access Now!
SYK - EPS vs FCF / Share
7-Day FREE Trial Get Full Access Now!
SYK - EPS vs PE Ratio
7-Day FREE Trial Get Full Access Now!
SYK - FCF vs FCF / Share
7-Day FREE Trial Get Full Access Now!
SYK - FCF vs Stock Based Comp
7-Day FREE Trial Get Full Access Now!
SYK - Cash & Debt
7-Day FREE Trial Get Full Access Now!
SYK - Dividends
7-Day FREE Trial Get Full Access Now!
SYK Dividend CAGR:1Y: 4.76%2Y: 4.88%5Y: 6.91%10Y: 8.76%
SYK - Revenue by Segment
7-Day FREE Trial Get Full Access Now!
SYK Revenue CAGR:1Y: 9.42%2Y: 10.24%5Y: 8.94%10Y: 8.78%
SYK - Revenue by Region
7-Day FREE Trial Get Full Access Now!
SYK Revenue CAGR:1Y: 9.42%2Y: 10.24%5Y: 8.94%10Y: 8.78%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

SYK - REVENUE: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
SYK Actual Revenue CAGR:1Y: 9.42%2Y: 10.24%5Y: 8.94%10Y: 8.78%
SYK - EPS: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
SYK Actual EPS CAGR:1Y: 44.10%2Y: 24.18%5Y: 16.32%10Y: 12.68%
SYK - NET INCOME: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
SYK Actual Net Income CAGR:1Y: 44.34%2Y: 24.37%5Y: 16.60%10Y: 12.88%
SYK - EBITDA: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
SYK Actual EBITDA CAGR:1Y: 6.32%2Y: 9.31%5Y: 6.81%10Y: 8.36%

Ratios, Profit Margins & Return on Capital:

SYK - Net Profit Margin
7-Day FREE Trial Get Full Access Now!
SYK Net Profit Margin CAGR:1Y: 31.95%2Y: 12.81%5Y: 7.03%10Y: 3.77%
SYK - Gross Profit Margin
7-Day FREE Trial Get Full Access Now!
SYK Gross Profit Margin CAGR:1Y: 9.64%2Y: 5.52%5Y: 1.12%10Y: 0.51%
SYK - Price to Earnings
7-Day FREE Trial Get Full Access Now!
SYK - Price To Sales Ratio
7-Day FREE Trial Get Full Access Now!
SYK - Return on Capital Employed
7-Day FREE Trial Get Full Access Now!
SYK - Return on Invested Capital
7-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

SYK Dividends Info:

Annual Dividend: $3.52
Forward Yield: 1.04%
Ex-Dividend Date: 2026-09-30
Lifetime Dividends / Share: $35.24

SYK Dividend History: Dates, Payments & Yield list

Below is a schedule of all SYK dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
09/30/202610/30/2026$0.8801.04%0%$0.00
06/30/202607/31/2026$0.8801.11%1.08%$325.70
03/31/202604/30/2026$0.8801.05%1.12%$315.13
12/31/202501/30/2026$0.8800.97%0.95%$369.56
09/30/202510/31/2025$0.8400.91%0.94%$356.24
06/30/202507/31/2025$0.8400.84%0.86%$392.73
03/31/202504/30/2025$0.8400.88%0.9%$373.92
12/31/202401/31/2025$0.8400.9%0.86%$391.29
09/30/202410/31/2024$0.8000.89%0.9%$356.28
06/28/202407/31/2024$0.8000.93%0.98%$327.45
03/27/202404/30/2024$0.8000.86%0.95%$336.50
12/28/202301/31/2024$0.8001.02%0.95%$335.48
09/28/202310/31/2023$0.7501.1%1.11%$270.22
06/29/202307/31/2023$0.7500.75%1.06%$283.41
03/30/202304/28/2023$0.7500.53%1%$299.65
12/29/202201/31/2023$0.7501.15%1.18%$253.81
09/29/202210/31/2022$0.6951.35%1.21%$229.24
06/29/202207/29/2022$0.6951.36%1.29%$214.75
03/30/202204/29/2022$0.6950.98%1.15%$241.26
12/30/202101/31/2022$0.6950.96%1.12%$248.05
09/29/202110/29/2021$0.6300.94%0.95%$266.07
06/29/202107/30/2021$0.6300.95%0.93%$270.94
03/30/202104/30/2021$0.6300.99%0.96%$262.63
12/30/202001/29/2021$0.6300.97%1.14%$221.01
09/29/202010/30/2020$0.5751.12%1.14%$202.01
06/29/202007/31/2020$0.5751.26%1.19%$193.30
03/30/202004/30/2020$0.5751.34%1.23%$186.43
12/30/201901/31/2020$0.5751.02%1.09%$210.70
09/27/201910/31/2019$0.5200.97%0.96%$216.27
06/27/201907/31/2019$0.5201%0.99%$209.78
03/28/201904/30/2019$0.5201.01%1.1%$188.91
12/28/201801/31/2019$0.5201.25%1.17%$177.57
09/27/201810/31/2018$0.4701.07%1.16%$162.22
06/28/201807/31/2018$0.4701.09%1.15%$163.25
03/28/201804/30/2018$0.4701.13%1.11%$169.42
12/28/201701/31/2018$0.4701.12%1.14%$164.38
09/28/201710/31/2017$0.4251.21%1.1%$154.87
06/28/201707/31/2017$0.4251.18%1.16%$147.10
03/29/201704/28/2017$0.4251.22%1.25%$136.37
12/28/201601/31/2017$0.4251.31%1.38%$123.53
09/28/201610/31/2016$0.3801.3%1.32%$115.35
06/28/201607/29/2016$0.3801.28%1.31%$116.28
03/29/201604/29/2016$0.3801.36%1.39%$109.01
12/29/201501/29/2016$0.3801.49%1.53%$99.15
09/28/201510/30/2015$0.3451.49%1.44%$95.62
06/26/201507/31/2015$0.3451.38%1.35%$102.27
03/27/201504/30/2015$0.3451.4%1.5%$92.24
12/29/201401/30/2015$0.3451.32%1.52%$91.05
09/26/201410/31/2014$0.3051.5%1.39%$87.53
06/26/201407/31/2014$0.3051.39%1.53%$79.77
03/27/201404/30/2014$0.3051.43%1.57%$77.75
12/27/201301/31/2014$0.3051.47%1.57%$77.60
09/26/201310/31/2013$0.2651.55%1.44%$73.86
06/26/201307/31/2013$0.2651.56%1.5%$70.46
03/26/201304/30/2013$0.2651.47%1.62%$65.58
12/27/201201/31/2013$0.2651.64%1.69%$62.65
09/26/201210/31/2012$0.2131.53%1.62%$52.60
06/27/201207/31/2012$0.2131.5%1.63%$52.03
03/28/201204/30/2012$0.2131.43%1.56%$54.57
12/27/201101/31/2012$0.2131.51%1.53%$55.43
09/28/201110/31/2011$0.1801.48%1.5%$47.91
06/28/201107/29/2011$0.1801.18%1.32%$54.34
03/29/201104/29/2011$0.1801.08%1.22%$59.00
12/29/201001/31/2011$0.1801.16%1.25%$57.56
09/28/201010/29/2010$0.1501.2%1.21%$49.49
06/28/201007/30/2010$0.1501.08%1.29%$46.57
03/26/201004/30/2010$0.1500.71%1.04%$57.44
12/28/200901/29/2010$0.1501.27%1.16%$51.92
11/16/200912/16/2009$0.1001.01%0.77%$52.20
12/29/200801/30/2009$0.4001.02%3.79%$42.24
12/27/200701/31/2008$0.3300.44%1.97%$66.97
12/27/200601/31/2007$0.2200.6%1.42%$61.94
12/28/200501/31/2006$0.1100.44%0.88%$49.90
12/29/200401/31/2005$0.0900.19%0.73%$49.14
12/29/200301/30/2004$0.0700.17%0.63%$44.37
12/27/200201/31/2003$0.0600.18%0.8%$30.12
12/27/200101/31/2002$0.0500.17%0.68%$29.37
12/27/200001/31/2001$0.0400.29%0.71%$22.60
12/29/199901/31/2000$0.0330.19%0.82%$15.81
12/29/199801/29/1999$0.0080.06%0.26%$11.59
12/29/199701/30/1998$0.0280.29%1.19%$9.23
12/27/199601/01/1997$0.0060.08%0.34%$7.41
12/27/199501/31/1996$0.0030.04%0.16%$6.98
12/23/199412/28/1994$0.0020.1%0.2%$4.55
12/27/199312/29/1993$0.0020.06%0.23%$3.66
12/24/199212/28/1992$0.0010.02%0.09%$4.56
12/24/199112/26/1991$0.0020.03%0.1%$5.94

Projected Future Returns & Dividends for SYK

Based on past 10-year performance, here are SYK growth metrics:

Share price CAGR of +11.57%
Dividend CAGR of +8.76%

Using SYK CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

SYK (DRIP)SYK - No DRIP
Current Price$338.02$338.02
Start Shares29.5829.58
Start Value$10,000$10,000
  
After 10 years:
Final Share Count32.4729.58
Dividends Payment$2.04$2.04
Annual Dividends$265$241
Yield on cost2.65%2.41%
Share Price$1,009.79$1,009.79
Total Dividends$1,651$1,564
Final Value$32,786$31,438

Estimated Future Value + Dividends - SYK

NOTE: Above numbers are our estimate based on SYK's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

[lev_ptables no_sale]

Company Info

Stryker Corporation (SYK) had its IPO on 1980-03-17, and is trader on NYSE stock exchange.

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

SYK website: https://www.stryker.com


Get Full Access to All Reports with DRIPCalc PRO

[lev_ptables no_sale]